Lv43
470 积分 2024-09-06 加入
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
11个月前
已完结
HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome
11个月前
已关闭
Electrical power generation from moderate-temperature radiative thermal sources
11个月前
已关闭
皖公网安备34019202002308
